Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nanos homolog 3 (NANOS3) is an evolutionarily conserved RNA-binding protein featuring two unique C2HC-type zinc finger motifs that are indispensable for its function in germ cell development and maintenance[1][2][4][5]. NANOS3 is expressed in human gonads, localizing predominantly to the nuclei of germ cells during spermatogenesis and oogenesis[2][4]. Its primary biological role is to maintain germ cell populations by regulating the expression of genes required for pluripotency and proper meiotic initiation; NANOS3 acts as an anti-apoptotic factor in primordial germ cells, protecting them during critical developmental windows[2][3][4]. Loss or reduction of NANOS3 function leads to decreased germ cell numbers and is associated with disorders such as primary ovarian insufficiency and infertility, likely through impaired anti-apoptotic activity and disturbed gene regulation[4]. NANOS3 functions by binding RNA—without strict sequence specificity—and collaborates with other translational regulators such as Pumilio to repress mRNA translation during early germ cell development[1][5]. There are currently no drugs or established therapeutic mechanisms directly targeting NANOS3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nanos homolog 3 (NANOS3).